SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Continental Resources, Inc. (CLR)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - October 17, 2022) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Continental Resources, Inc. ("Continental Resources" or the "Company") (NYSE: CLR) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to be acquired by Omega Acquisition, Inc., an Oklahoma corporation ("Merger Sub"), an entity that is...
2022-10-17 12:23 PM EDT
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Archaea Energy Inc. (LFG)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - October 17, 2022) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Archaea Energy Inc. ("Archaea" or the "Company") (NYSE: LFG) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to be acquired by bp (NYSE: BP). Under the terms of the Merger Agreement, bp will pay approximately $26 per Archaea Class A...
2022-10-17 12:05 PM EDT
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Albertsons Companies, Inc. (ACI)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - October 14, 2022) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Albertsons Companies, Inc. ("Albertsons" or the "Company") (NYSE: ACI) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to merge with Kroger (NYSE: KR). Under the terms of the merger agreement, Kroger will acquire all of the outstanding...
2022-10-14 9:28 AM EDT
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Imara, Inc. (IMRA)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - October 14, 2022) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Imara, Inc. (NASDAQ: IMRA) ("Imara" or the "Company") for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to merge with Enliven Therapeutics, Inc. ("Enliven"). Under the terms of the merger agreement, Imara will issue to pre-merger Enliven...
2022-10-14 7:30 AM EDT